Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

Kotecha R, Polley MY, Vogelbaum MA, Perry A, Ashby L, Modi JM, Alleman AM, Tsien CI, Barani IJ, Li J, Braunstein S, Whitton AC, Bovi JA, Deb N, Lindhorst SM, Shrieve DC, Robinson CG, Shu HG, Vempati P, Mishra MV, Suh JH, Bloom B, Hunter GK, Won M, Mehta MP, Rogers CL